Lushang Freda Pharmaceutical financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
¥2.45B ¥2.17B ¥1.40B ¥1.58B ¥2.61B ¥2.50B ¥3.02B ¥2.38B ¥3.67B ¥5.29B ¥5.68B ¥5.86B ¥7.65B ¥8.29B ¥8.82B ¥10.29B ¥13.62B ¥12.36B ¥12.95B ¥4.58B ¥0.00M
GM % Gross Margin %
7.00% 3.82% -44.68% 3.30% 14.98% 36.14% 33.86% 27.16% 29.93% 28.21% 22.35% 19.71% 14.61% 18.61% 20.18% 20.99% 20.27% 24.10% 22.59% 46.33% 0.00%
OM Operating Margin
4.18% -1.09% -51.53% -8.58% 1.98% 23.10% 20.38% 12.57% 13.01% 10.15% 6.70% 4.73% 3.03% 4.19% 5.48% 4.17% 5.63% 5.15% 4.44% 4.97% 0.00%
EPS Earnings Per Share
¥0.46 ¥0.22 ¥0.25 ¥0.26 ¥0.13 ¥0.62 ¥0.06 ¥0.14 ¥0.00
Div. Dividends
¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.06 ¥0.00 ¥0.00 ¥0.15 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.11 ¥0.07 ¥0.10 ¥0.00
PR % Payout Ratio %
0 0 0 0 0 0 13.04% 0.00% 0.00% 57.69% 0 0 0 0 0 0 0 0 116.67% 71.43% 0
Sha. Shares
536.25m 536.25m 536.25m 536.25m 536.25m 1000.97m 1000.97m 1000.97m 1000.97m 1000.97m 1000.97m 1000.97m 1000.97m 1000.97m 1000.97m 1000.97m 1008.83m 1009.15m 1009.15m 0m 1016.57m
OCF Operating Cash Flow
¥337.65M ¥0.00M ¥-25.18M ¥-134.96M ¥-680.93M ¥48.39M ¥-1464.83M ¥-3633.91M ¥103.59M ¥-1087.85M ¥-2363.10M ¥-1797.51M ¥-2468.12M ¥1.64B ¥2.10B ¥-3307.18M ¥4.45B ¥6.85B ¥998.10M ¥474.15M ¥0.00M
FCF Free Cash Flow
¥-155.28M ¥0.00M ¥-55.62M ¥-186.38M ¥-736.05M ¥45.00M ¥-1472.08M ¥-3654.59M ¥-88.98M ¥-1102.01M ¥-2368.20M ¥-1812.39M ¥-2493.48M ¥1.55B ¥2.06B ¥-3367.38M ¥4.29B ¥6.57B ¥837.68M ¥5.25B ¥0.00M
FCFS Free Cash Flow Per Share
¥0.00 ¥0.00 ¥-0.10 ¥-0.18 ¥-0.74 ¥0.04 ¥-1.47 ¥-3.65 ¥-0.09 ¥-1.09 ¥-2.41 ¥-1.77 ¥-2.43 ¥1.58 ¥2.04 ¥-3.32 ¥4.30 ¥6.53 ¥0.73 ¥0.26 ¥0.00